Debro Inc.

Chemical Technology

Twelve | July 04, 2022

Twelve, the carbon transformation company, is announcing $130 million in Series B and additional funding to scale the engineering, manufacturing, and deployment of its industrial-scale carbon transformation technology for the creation of a wide range of products with a lower carbon footprint. Twelve’s carbon transformation technology converts captured CO2 into products historically made from fossil fuels. According to research from Columbia’s SIPA Center on Global Ener...

Chemical Technology

DISTRUPOL | June 17, 2021

Distrupol, a major European distributor of thermoplastics and elastomers to the polymer processing industry and a subsidiary of GPD Companies, Inc., announced the acquisition of Lautrup Chemicals A/S today. The transaction's terms were not disclosed. Lautrup Chemicals, founded in 1982 by Chief Executive Officer and President Hans Lautrup, is the biggest distributor of polymers in Scandinavia. The Company offers a varied client base in the Nordic area and Eastern and Southern E...

Chemical Management

Advent Technologies Holdings, Inc. | December 21, 2021

Advent Technologies Holdings, Inc. announced that its fuel cell unit for the Maritime Sector – developed within the frame of the RiverCell Consortium – has passed safety testing, as well as a safety assessment completed by DNV, one of the world's leading classification societies. RiverCell, a demonstration project supported by a consortium of partners, was initiated in 2015 and is expected to be completed by the end of this year. Funded by Germany’s Federal M...

Prnewswire | October 09, 2020

Patients who recovered from COVID-19 at St. Luke's University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans. The "convalescent plasma" was separated from the survivors' blood and is being studied as part of a research project labeled AR-701, sponsored by Aridis Pharmaceuticals, a biopharmaceutical firm in San Jose, Ca., th...